Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MNCs Applaud Shanghai Zhangjiang Hi-tech Park Pilot Program To Accelerate Biomaterial Imports

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Ten research centers in Shanghai Zhangjiang Hi-tech Park have passed inspections by the General Administration of Quality Supervision, Inspection and Quarantine for the first round of a pilot program aimed at simplifying import procedures and at shortening the time it takes to approve imported biomaterial
Advertisement

Related Content

BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
Shanghai Hi-Tech Park Acquires Stake In Medical Devices Company MicroPort As Part Of Overhaul Of Shanghai Pharmaceutical Industry
Shanghai Hi-Tech Park Acquires Stake In Medical Devices Company MicroPort As Part Of Overhaul Of Shanghai Pharmaceutical Industry
In Wake Of Heparin Deaths, FDA Set To Launch Pilot Project Aimed At Preventing Imports Of Adulterated Drugs
In Wake Of Heparin Deaths, FDA Set To Launch Pilot Project Aimed At Preventing Imports Of Adulterated Drugs
Advertisement
UsernamePublicRestriction

Register

SC071017

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel